✦ LIBER ✦

Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease

✍ Scribed by A. H. V. Schapira; P. Barone; R. A. Hauser; Y. Mizuno; O. Rascol; M. Busse; C. Debieuvre; M. Fraessdorf; W. Poewe

Book ID: 117953309
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 540 KB
Volume: 20
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2012.03822.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and tolerability of ov

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop

P2.155 Simple overnight switching from i

P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage

✍ O. Rascol; P. Barone; R. Hauser; Y. Mizuno; W. Poewe; A. Schapira; C. Debieuvre; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Long-term safety and sustained efficacy

Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease

✍ Hauser, R. A.; Schapira, A. H. V.; Barone, P.; Mizuno, Y.; Rascol, O.; Busse, M. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 637 KB

2.265 LONG-TERM SAFETY AND SUSTAINED EFF

2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE

✍ W. Poewe; P. Barone; R. Hauser; Y. Mizuno; O. Rascol; M. Busse; C. Debieuvre; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Budget Impact of Switching Pramipexole I

Budget Impact of Switching Pramipexole Immediate Release to Pramipexole Extended Release in Treatment of Parkinson’s Disease; Perspective of the Social Security Institution

✍ Kececioglu, S.; Ulus, P.; Cukadar, F.; Urganci, B.; Ozkan, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

P2.089 Efflcacy of pramipexole extended

P2.089 Efflcacy of pramipexole extended release (ER) and switching from pramipexole immediate release (IR) to ER in Japanese advanced PD patients

✍ Y. Mizuno; M. Yamamoto; S. Kuno; K. Hasegawa; T. Kagimura; N. Hattori 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB